TW201439540A - 以游離輻射製備檢驗試劑載體之方法 - Google Patents
以游離輻射製備檢驗試劑載體之方法 Download PDFInfo
- Publication number
- TW201439540A TW201439540A TW102111981A TW102111981A TW201439540A TW 201439540 A TW201439540 A TW 201439540A TW 102111981 A TW102111981 A TW 102111981A TW 102111981 A TW102111981 A TW 102111981A TW 201439540 A TW201439540 A TW 201439540A
- Authority
- TW
- Taiwan
- Prior art keywords
- magnetic
- free radiation
- carbon nanotube
- preparing
- radiation according
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title description 3
- 230000005865 ionizing radiation Effects 0.000 title 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims abstract description 47
- 239000002041 carbon nanotube Substances 0.000 claims abstract description 45
- 229910021393 carbon nanotube Inorganic materials 0.000 claims abstract description 45
- 230000005855 radiation Effects 0.000 claims abstract description 27
- 229920001223 polyethylene glycol Polymers 0.000 claims abstract description 24
- 239000000427 antigen Substances 0.000 claims abstract description 20
- 102000036639 antigens Human genes 0.000 claims abstract description 20
- 108091007433 antigens Proteins 0.000 claims abstract description 20
- 206010028980 Neoplasm Diseases 0.000 claims abstract description 13
- 239000002253 acid Substances 0.000 claims abstract description 9
- 238000001514 detection method Methods 0.000 claims abstract description 9
- 239000002114 nanocomposite Substances 0.000 claims description 29
- 239000002202 Polyethylene glycol Substances 0.000 claims description 17
- 239000003153 chemical reaction reagent Substances 0.000 claims description 17
- 238000000034 method Methods 0.000 claims description 17
- 238000012360 testing method Methods 0.000 claims description 13
- GUTLYIVDDKVIGB-OUBTZVSYSA-N Cobalt-60 Chemical compound [60Co] GUTLYIVDDKVIGB-OUBTZVSYSA-N 0.000 claims description 12
- 239000012491 analyte Substances 0.000 claims description 10
- 201000011510 cancer Diseases 0.000 claims description 9
- 238000003745 diagnosis Methods 0.000 claims description 9
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 6
- 125000000524 functional group Chemical group 0.000 claims description 6
- 239000000463 material Substances 0.000 claims description 6
- 210000002966 serum Anatomy 0.000 claims description 6
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 5
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 5
- 102000004169 proteins and genes Human genes 0.000 claims description 5
- 108090000623 proteins and genes Proteins 0.000 claims description 5
- 239000000941 radioactive substance Substances 0.000 claims description 5
- 239000000126 substance Substances 0.000 claims description 5
- 108091034117 Oligonucleotide Proteins 0.000 claims description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 4
- PNDPGZBMCMUPRI-XXSWNUTMSA-N [125I][125I] Chemical compound [125I][125I] PNDPGZBMCMUPRI-XXSWNUTMSA-N 0.000 claims description 4
- 238000005259 measurement Methods 0.000 claims description 4
- 239000012857 radioactive material Substances 0.000 claims description 4
- 238000011156 evaluation Methods 0.000 claims description 3
- 238000000338 in vitro Methods 0.000 claims description 3
- 238000012986 modification Methods 0.000 claims description 3
- 230000004048 modification Effects 0.000 claims description 3
- CWYNVVGOOAEACU-UHFFFAOYSA-N Fe2+ Chemical compound [Fe+2] CWYNVVGOOAEACU-UHFFFAOYSA-N 0.000 claims description 2
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical group O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 claims description 2
- 125000003277 amino group Chemical group 0.000 claims description 2
- 230000027455 binding Effects 0.000 claims description 2
- 150000001720 carbohydrates Chemical class 0.000 claims description 2
- 229940044173 iodine-125 Drugs 0.000 claims description 2
- 229910017604 nitric acid Inorganic materials 0.000 claims description 2
- 108020004707 nucleic acids Proteins 0.000 claims description 2
- 102000039446 nucleic acids Human genes 0.000 claims description 2
- 150000007523 nucleic acids Chemical class 0.000 claims description 2
- 150000002148 esters Chemical class 0.000 claims 1
- SZVJSHCCFOBDDC-UHFFFAOYSA-N ferrosoferric oxide Chemical compound O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 claims 1
- 125000002485 formyl group Chemical class [H]C(*)=O 0.000 claims 1
- 125000004356 hydroxy functional group Chemical group O* 0.000 claims 1
- 150000003573 thiols Chemical class 0.000 claims 1
- 230000035945 sensitivity Effects 0.000 abstract description 5
- 239000003795 chemical substances by application Substances 0.000 abstract 2
- 229910017052 cobalt Inorganic materials 0.000 abstract 1
- 239000010941 cobalt Substances 0.000 abstract 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 abstract 1
- 238000002372 labelling Methods 0.000 abstract 1
- 239000006249 magnetic particle Substances 0.000 abstract 1
- 201000010099 disease Diseases 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 238000005516 engineering process Methods 0.000 description 6
- 229910021392 nanocarbon Inorganic materials 0.000 description 5
- 238000001179 sorption measurement Methods 0.000 description 5
- 239000000969 carrier Substances 0.000 description 4
- 229920000642 polymer Polymers 0.000 description 4
- 239000012620 biological material Substances 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 238000002965 ELISA Methods 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 238000003018 immunoassay Methods 0.000 description 2
- 239000002105 nanoparticle Substances 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000003380 quartz crystal microbalance Methods 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 238000002198 surface plasmon resonance spectroscopy Methods 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 239000004705 High-molecular-weight polyethylene Substances 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 238000010306 acid treatment Methods 0.000 description 1
- 125000003172 aldehyde group Chemical group 0.000 description 1
- 230000009830 antibody antigen interaction Effects 0.000 description 1
- 239000005312 bioglass Substances 0.000 description 1
- 230000000120 cytopathologic effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000003891 environmental analysis Methods 0.000 description 1
- 125000004185 ester group Chemical group 0.000 description 1
- 238000007306 functionalization reaction Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 239000011553 magnetic fluid Substances 0.000 description 1
- 238000002595 magnetic resonance imaging Methods 0.000 description 1
- 230000009871 nonspecific binding Effects 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 238000003752 polymerase chain reaction Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54353—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand attached to the carrier via a chemical coupling agent
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54393—Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/551—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being inorganic
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2446/00—Magnetic particle immunoreagent carriers
- G01N2446/10—Magnetic particle immunoreagent carriers the magnetic material being used to coat a pre-existing polymer particle but not being present in the particle core
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Peptides Or Proteins (AREA)
- Carbon And Carbon Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
一種以游離輻射製備奈米檢驗試劑之方法，係為一奈米碳管（Carbon Nano Tube, CNT），經酸處理及鈷-60游離輻射照射，造成該奈米碳管表面改質，形成不同之官能基接枝後，加入磁性分子以鈷-60游離輻射照射方式使該磁性分子吸附於該奈米碳管上，再利用高分子聚乙二醇（Polyethylene Glycols, PEG）以化學鍵結修飾此具有磁性分子之奈米碳管表面，可使抗體或抗原得以輕易被吸附至此奈米碳管上之磁性奈米複合材。藉此，作為可專一性地標定多種癌症之奈米檢驗試劑，可提高偵測靈敏度並降低偽訊號產生，以達到特定疾病之診斷目的，可應用於臨床大量例行活體外定量量測癌症診斷與治療之評估。
Description
本發明係有關於一種以游離輻射製備奈米檢驗試劑之方法，尤指涉及一種利用高分子聚乙二醇（Polyethylene Glycols, PEG）以化學鍵結修飾具有磁性分子之奈米碳管表面所構成之磁性奈米複合材，特別係指作為可專一性地標定多種癌症之奈米檢驗試劑 ，可提高 偵測靈敏度 並降低偽訊號產生，以達到特定疾病診斷之目的。
通常要將一般材料接上疾病（尤指癌症）之專一性抗原/抗體（Antigen/Antibody）並不容易且吸附力不強，抗原/抗體容易在處理過程中脫落或破壞其蛋白質結構，失去其活性。因此，有許多用來改良吸附生物材料之方法被提出，例如載體之開發一直為分離純化技術主要之研究方向，近年來奈米碳載體備受重視，其中奈米碳官能基化後之磁性載體之技術，在奈米碳表面會產生官能基，影響對於生物材料之吸附效應。即當抗原或係抗體與官能基化之磁性奈米碳結合後，另外再加入磁性分子以加熱方式使其貼附於奈米微粒上，於一外加磁場之存在下，則可輕易地操控它移至某處或者另一狀態。自1991年代時，奈米碳在製備巴克球（Bucky Ball，碳60）之實驗產物中被發現，由於奈米碳管在物性、化性或材料特性上具有相當優越之性能，包含質量輕、高韌性、可撓曲性高、表面積大、高熱傳導性等特性，因此衍生出許多廣泛之應用，受到相當矚目。另外，為了研究分離生物性材料之技術，開始有一些學者將磁性載體技術應用於分離技術中，作為一種利用磁場將目標物分離之分離技術，目前已廣泛應用於醫療診斷、DNA、RNA純化、蛋白質、酵素之固定化、免疫分析與環境分析、及磁性流體等領域中，例如將其與特定之抗原/抗體結合後，這些磁性載體就具有高生物選擇性，並可以吸附特定疾病及病毒所具有之DNA、RNA或抗原/抗體。
有鑑於此，在尚未導致癌症之非誘發細胞病變效應（Noncytopathic, NCP）時期，對疾病之偵測及診斷將有助於早期診斷病灶，進而提高治癒癌症之機率，一般臨床上對疾病之偵測及診斷主要依賴基於抗體-抗原交互作用之免疫分析，且目前已包括有酵素連接免疫吸收分析（Enzyme-Linked Immunosorbent Assay, ELISA）、化學冷光呈色（Chemiluminesce）、聚合酶連鎖反應（Polymerase Chain Reaction，PCR）、表面電漿共振（Surface Plasmon Resonance, SPR）、電化學石英晶體微天平（Electrochemical QCM, EQCM）或免疫聚合酶連鎖反應（Immuno-PCR）等檢驗方式提出。例如比較商業化之磁性載體，其係以生物玻璃基材作為磁性載體，惟其於水裡面會水解化掉，且當PH值改變時，其基材也會變化，故其穩定度不好；再者，該磁性載體上之OH基易與水分子結合，因此亦衍生非專一性結合（Non-Specific Binding）之問題，進而降低其靈敏度。故，ㄧ般習用者係無法符合使用者於實際使用時之所需。
本發明之主要目的係在於，克服習知技藝所遭遇之上述問題並提供一種利用高分子聚乙二醇以化學鍵結修飾具有磁性分子之奈米碳管表面所構成之磁性奈米複合材，藉此作為可專一性地標定多種癌症之奈米檢驗試劑 ，可提高 偵測靈敏度 並降低偽訊號產生，以達到特定疾病組織之磁振造影及診斷之目的，係可應用於臨床大量例行活體外定量量測癌症診斷與治療之評估方法 者。
為達以上之目的，本發明係一種以游離輻射製備奈米檢驗試劑之方法，係為一奈米碳管，經酸處理及鈷-60游離輻射照射，造成該奈米碳管表面改質，形成不同之官能基接枝後，加入磁性分子以鈷-60游離輻射照射方式使該磁性分子吸附於該奈米碳管上，再利用高分子聚乙二醇以化學鍵結修飾此具有磁性分子之奈米碳管表面，可使抗體或抗原得以輕易被吸附至此奈米碳管上之磁性奈米複合材，其包括：
一磁性奈米碳管；以及
一接枝官能性分子，係分佈於該磁性奈米碳管上，並接有一高分子聚乙二醇，用以將一活性分子結合於該磁性奈米碳管表面。
為達以上之目的，本發明係一種以游離輻射製備奈米檢驗試劑之方法，係為一奈米碳管，經酸處理及鈷-60游離輻射照射，造成該奈米碳管表面改質，形成不同之官能基接枝後，加入磁性分子以鈷-60游離輻射照射方式使該磁性分子吸附於該奈米碳管上，再利用高分子聚乙二醇以化學鍵結修飾此具有磁性分子之奈米碳管表面，可使抗體或抗原得以輕易被吸附至此奈米碳管上之磁性奈米複合材，其包括：
一磁性奈米碳管；以及
一接枝官能性分子，係分佈於該磁性奈米碳管上，並接有一高分子聚乙二醇，用以將一活性分子結合於該磁性奈米碳管表面。
1．．．磁性奈米複合材
11．．．奈米碳管
111．．．磁性分子
12．．．接枝官能性分子
121．．．聚乙二醇
2．．．活性分子
3．．．樣品
31．．．待測物
4．．．二級抗體
41．．．放射性物質
第１圖，係本發明磁性奈米複合材之製作流程示意圖。
第２圖，係本發明磁性奈米複合材之結構示意圖。
第３圖，係本發明之使用態樣流程示意圖
第２圖，係本發明磁性奈米複合材之結構示意圖。
第３圖，係本發明之使用態樣流程示意圖
請參閱『第１圖及第２圖』所示，係分別為本發明磁性奈米複合材之製作流程示意圖、及本發明磁性奈米複合材之結構示意圖。如圖所示：本發明係一種以游離輻射製備奈米檢驗試劑之方法，係為一奈米碳管１１（Carbon Nano Tube, CNT），經酸溶液處理及鈷-60游離輻射照射，造成該奈米碳管１１表面改質，形成不同之官能基接枝後，加入磁性分子 １１１以鈷-60游離輻射照射方式使該磁性分子１１１吸附於該奈米碳管１１上，再利用高分子聚乙二醇（Polyethylene Glycols, PEG）１２１以化學鍵結修飾此具有磁性分子１１１之奈米碳管１１表面，可使抗體或抗原得以輕易被吸附至此奈米碳管１１上之磁性奈米複合材１，其包括：
一奈米碳管１１，係分佈有一磁性分子１１１，其中，該磁性分子１１１係為可合成四氧化三鐵（Fe3O4）之二價鐵（Fe2+）；以及
一接枝官能性分子１２，係分佈於該磁性奈米碳管１１上，並接有一高分子聚乙二醇１２１，用以將一活性分子結合於該磁性奈米碳管１１表面，其中，該接枝官能性分子１２係含有一官能基，並可為羧基（-COOH）、胺基（-NH2）、硫醇基（-SH）、羥基（-OH）、醛基（-COH）或酯基（-COO-），俾利由酸接枝官能化。
當本發明於製備時，於一較佳實施例中，係將一群奈米碳管１１進行硝酸、硫酸或醋酸之酸溶液處理，及利用鈷-60游離輻射照射，使該奈米碳管１１上形成一接枝官能性分子１２，可於末端長出COOH之官能基，之後再將一磁性分子１１１加入該奈米碳管１１中，以鈷-60游離輻射照射方式使該磁性分子１１１附載於該奈米碳管１１上，最後以高分子聚乙二醇１２１修飾表面以提高水溶性、生物相容性並可避免被血清中之蛋白吸附達到專一性標的之目的，使每一奈米碳管１１在皆具有磁性同時，亦可藉由外圍接有之聚乙二醇１２１提高專一性結合率（Specific Binding），使本發明以此游離輻射製備而成之磁性奈米複合材１，作為可專一性地標定多種癌症之奈米檢驗試劑 ，可提高 偵測靈敏度 並降低偽訊號產生，以達到特定疾病診斷之目的。
請參閱『第３圖』所示，係本發明之使用態樣流程示意圖。如圖所示：本發明係可以上述磁性奈米複合材１應用於臨床大量例行活體外定量量測癌症診斷與治療之評估，其至少包含下列步驟：
（Ａ）提供一磁性奈米複合材１，該磁性奈米複合材１外圍係接有高分子聚乙二醇１２１，其表面並結合有一活性分子２可捕捉樣品３中之待測物３１，其中，該活性分子２係可為抗原（Antigen）、核酸、寡聚核 苷酸（Oligonucleotide）、蛋白質、醣類或抗體（Antibody）；
（Ｂ）將一樣品３加入該磁性奈米複合材１中，使該樣品３中之待測物３１與該磁性奈米複合材１表面之活性分子２產生特異性反應而進行捕捉；以及
（Ｃ）再加入一標識有放射性物質４１之二級抗體（ Secondary Antibody）４進行反應，使具有該放射性物質４１之二級抗體４標示該待測物３１，俾以此標示作為指標進行訊號偵測。
當本發明於運用時，於一較佳實施例中，係以上述磁性奈米複合材１作為載體之結構，利用其接枝官能性分子１２及其上高分子聚乙二醇１２１將一抗原２結合於該奈米微粒１１表面；繼之，藉由在一容器底部放置之磁鐵，使該磁性奈米複合材１中之磁性分子１１１對磁場起反應而往該磁鐵方向移動聚集，待將剩下沒反應之抗原２清洗去除後，即形成純粹帶有抗原２之磁性奈米複合材１；接著，加入一樣品３（即癌症病患之血清）於其中，利用對疾病具專一性吸附之磁性奈米複合材１，能僅將該血清中可與抗原２相對應之待測物３１，即一級抗體（Primary Antibody）接枝於該磁性奈米複合材１上，於其中，同樣施以一磁場將該磁性奈米複合材１聚集吸附住，未被吸附住之血清中之其他物質即被分離去除；最後，將此接上一級抗體之磁性奈米複合材１再接枝上二次抗體４，並再施以一磁場將其聚集吸附住，未被吸附住之二次抗體４即被分離去除，隨後即可利用該二次抗體４上標識之放射性物質４１，例如碘-125（I-125）檢測其訊號。
其中，若上述癌症病患血清中並無相對應之一級抗體時，該磁性奈米複合材１上之抗原２即不會進行捕捉，而隨後加入之二級體抗４亦同樣不會捕捉，自然在後續檢測放射性物質４１之訊號時即可避免訊號之偽陽性結果。
綜上所述，本發明係一種以游離輻射製備奈米檢驗試劑之方法，可有效改善習用之種種缺點，係為一奈米碳管（Carbon Nano Tube, CNT），經酸處理及鈷-60游離輻射照射，造成該奈米碳管表面改質，形成不同之官能基接枝後，加入磁性分子以鈷-60游離輻射照射方式使該磁性分子吸附於該奈米碳管上，再利用高分子聚乙二醇（Polyethylene Glycols, PEG）以化學鍵結修飾此具有磁性分子之奈米碳管表面，可使抗體或抗原得以輕易被吸附至此奈米碳管上之磁性奈米複合材，進而使本發明之産生能更進步、更實用、更符合使用者之所須，確已符合發明專利申請之要件，爰依法提出專利申請。
惟以上所述者，僅為本發明之較佳實施例而已，當不能以此限定本發明實施之範圍；故，凡依本發明申請專利範圍及發明說明書內容所作之簡單的等效變化與修飾，皆應仍屬本發明專利涵蓋之範圍內。
1．．．磁性奈米複合材
11．．．奈米碳管
111．．．磁性分子
12．．．接枝官能性分子
121．．．聚乙二醇
2．．．活性分子
3．．．樣品
31．．．待測物
4．．．二級抗體
41．．．放射性物質
Claims (10)
- 一種以游離輻射製備奈米檢驗試劑之方法，係為一奈米碳管（Carbon Nano Tube, CNT），經酸溶液處理及鈷-60游離輻射照射，造成該奈米碳管表面改質，形成不同之官能基接枝後，加入磁性分子以鈷-60游離輻射照射方式使該磁性分子吸附於該奈米碳管上，再利用高分子聚乙二醇（Polyethylene Glycols, PEG）以化學鍵結修飾此具有磁性分子之奈米碳管表面，可使抗體或抗原得以輕易被吸附至此奈米碳管上之磁性奈米複合材，其包括：
一磁性奈米碳管；以及
一接枝官能性分子，係分佈於該磁性奈米碳管上，並接有一高分子聚乙二醇，用以將一活性分子結合於該磁性奈米碳管表面。 - 依據申請專利範圍第１項所述之以游離輻射製備奈米檢驗試劑之方法，其中，該奈米碳管於酸溶液處理及鈷-60游離輻射後係加入可合成四氧化三鐵（Fe3O4）之二價鐵（Fe2+）之磁性分子。
- 依據申請專利範圍第１項所述之以游離輻射製備奈米檢驗試劑之方法，其中，該接枝官能性分子係經酸溶液處理及鈷-60游離輻射照射所形成。
- 依據申請專利範圍第１項所述之以游離輻射製備奈米檢驗試劑之方法，其中，該接枝官能性分子係含有一官能基，並可為羧基（-COOH）、胺基（-NH2）、硫醇基（-SH）、羥基（-OH）、醛基（-COH）或酯基（-COO-）。
- 依據申請專利範圍第１項所述之以游離輻射製備奈米檢驗試劑之方法，其中，該酸溶液處理係為硝酸、醋酸或硫酸。
- 依據申請專利範圍第１項所述之以游離輻射製備奈米檢驗試劑之方法，其中，該活性分子係為抗原（Antigen）、核酸、寡聚核 苷酸（Oligonucleotide）、蛋白質、醣類或抗體（Antibody）。
- 依據申請專利範圍第１項所述之以游離輻射製備奈米檢驗試劑之方法，係可應用於臨床大量例行活體外定量量測癌症診斷與治療之評估，其至少包含下列步驟：
（Ａ）提供一磁性奈米複合材，該磁性奈米複合材外圍係接有高分子聚乙二醇，其表面並結合有一活性分子可捕捉樣品中之待測物；
（Ｂ）將一樣品加入該磁性奈米複合材中，使該樣品中之待測物與該磁性奈米複合材表面之活性分子產生特異性反應而進行捕捉；以及
（Ｃ）再加入一標識有放射性物質之二級抗體（ Secondary Antibody）進行反應，使具有該放射性物質之二級抗體標示該待測物，俾以此標示作為指標進行訊號偵測。 - 依據申請專利範圍第７項所述之以游離輻射製備奈米檢驗試劑之方法，其中，該樣品係為癌症病患之血清。
- 依據申請專利範圍第７項所述之以游離輻射製備奈米檢驗試劑之方法，其中，該待測物係為一級抗體（Primary Antibody）。
- 依據申請專利範圍第７項所述之以游離輻射製備奈米檢驗試劑之方法，其中，該放射性物質係可為碘-125（I-125）。
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TW102111981A TWI541505B (zh) | 2013-04-02 | 2013-04-02 | 以游離輻射製備檢驗試劑載體之方法 |
| JP2013143158A JP5674870B2 (ja) | 2013-04-02 | 2013-07-09 | 磁性ナノ複合材の作製方法及び磁性ナノ複合材を用いた測定方法 |
| US13/958,845 US20140295574A1 (en) | 2013-04-02 | 2013-08-05 | Method of Fabricating Testing Reagent Carrier through Ionizing Radiation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TW102111981A TWI541505B (zh) | 2013-04-02 | 2013-04-02 | 以游離輻射製備檢驗試劑載體之方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TW201439540A true TW201439540A (zh) | 2014-10-16 |
| TWI541505B TWI541505B (zh) | 2016-07-11 |
Family
ID=51621240
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW102111981A TWI541505B (zh) | 2013-04-02 | 2013-04-02 | 以游離輻射製備檢驗試劑載體之方法 |
Country Status (3)
| Country | Link |
|---|---|
| US (1) | US20140295574A1 (zh) |
| JP (1) | JP5674870B2 (zh) |
| TW (1) | TWI541505B (zh) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109037651B (zh) * | 2018-08-14 | 2021-08-03 | 南通百川新材料有限公司 | 一种改性碳纳米管负极材料的制备方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1451844A4 (en) * | 2001-06-14 | 2008-03-12 | Hyperion Catalysis Int | FIELD EMISSION DEVICES USING MODIFIED CARBON NANOTUBES |
| US20060054488A1 (en) * | 2001-11-29 | 2006-03-16 | Harmon Julie P | Carbon nanotube/polymer composites resistant to ionizing radiation |
| WO2004070349A2 (en) * | 2002-11-27 | 2004-08-19 | William Marsh Rice University | Functionalized carbon nanotube-polymer composites and interactions with radiation |
| JP4860913B2 (ja) * | 2004-05-14 | 2012-01-25 | 富士通株式会社 | カーボンナノチューブ複合材料及びその製造方法、並びに、磁性材料及びその製造方法 |
| US20080175892A1 (en) * | 2006-08-18 | 2008-07-24 | Wilson Lon J | Nanostructure-Drug Conjugates |
| US20080318026A1 (en) * | 2007-06-25 | 2008-12-25 | University Of Dayton | Method of modifying carbon nanomaterials, composites incorporating modified carbon nanomaterials and method of producing the composites |
| WO2011029052A2 (en) * | 2009-09-04 | 2011-03-10 | Northwestern University | Primary carbon nanoparticles |
| WO2011087548A2 (en) * | 2009-10-27 | 2011-07-21 | William Marsh Rice University | Therapeutic compositions and methods for targeted delivery of active agents |
-
2013
- 2013-04-02 TW TW102111981A patent/TWI541505B/zh not_active IP Right Cessation
- 2013-07-09 JP JP2013143158A patent/JP5674870B2/ja not_active Expired - Fee Related
- 2013-08-05 US US13/958,845 patent/US20140295574A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| TWI541505B (zh) | 2016-07-11 |
| JP5674870B2 (ja) | 2015-02-25 |
| JP2014202743A (ja) | 2014-10-27 |
| US20140295574A1 (en) | 2014-10-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kaya et al. | Pathogen detection with electrochemical biosensors: Advantages, challenges and future perspectives | |
| Wang et al. | Electrochemical biosensors based on antibody, nucleic acid and enzyme functionalized graphene for the detection of disease-related biomolecules | |
| Xi et al. | Selection of HBsAg-specific DNA aptamers based on carboxylated magnetic nanoparticles and their application in the rapid and simple detection of hepatitis B virus infection | |
| Yu et al. | Reduced graphene oxide nanocomposite based electrochemical biosensors for monitoring foodborne pathogenic bacteria: A review | |
| Hassanpour et al. | Recent trends in rapid detection of influenza infections by bio and nanobiosensor | |
| Rocha-Santos | Sensors and biosensors based on magnetic nanoparticles | |
| Lee et al. | Nanomaterial-based biosensor as an emerging tool for biomedical applications | |
| Sonawane et al. | Surface modification chemistries of materials used in diagnostic platforms with biomolecules | |
| Xu et al. | Electrochemical biosensors based on magnetic micro/nano particles | |
| Krejcova et al. | Nanoscale virus biosensors: state of the art | |
| Jandas et al. | Effective utilization of quartz crystal microbalance as a tool for biosensing applications | |
| Wang et al. | Label-free immunoassay for sensitive and rapid detection of the SARS-CoV-2 antigen based on functionalized magnetic nanobeads with chemiluminescence and immunoactivity | |
| Peng et al. | Fluorescent-magnetic-catalytic nanospheres for dual-modality detection of H9N2 avian influenza virus | |
| Yang et al. | Graphene oxide based ultrasensitive flow-through chemiluminescent immunoassay for sub-picogram level detection of chicken interferon-γ | |
| Mohsin et al. | Design of aptamer-based sensing platform using gold nanoparticles functionalized reduced graphene oxide for ultrasensitive detection of Hepatitis B virus | |
| Elingarami et al. | Surface-engineered magnetic nanoparticles for molecular detection of infectious agents and cancer | |
| Moulick et al. | Advanced nanotechnologies in avian influenza: current status and future trends–a review | |
| JP2014202742A (ja) | ナノ炭素輻射キャリア改質方法 | |
| Ovais et al. | Engineering carbon nanotubes for sensitive viral detection | |
| Slimani et al. | Magnetic nanosensors and their potential applications | |
| Wang et al. | Applications of electrochemical biosensors based on functional antibody-modified screen-printed electrodes: a review | |
| Wang et al. | Aptamer‐functionalized field‐effect transistor biosensors for disease diagnosis and environmental monitoring | |
| Ayyar et al. | Antibody-based biosensors for detection of veterinary viral pathogens | |
| TWI541505B (zh) | 以游離輻射製備檢驗試劑載體之方法 | |
| Blel et al. | Ultrasensitive electrochemical sensors for psa detection: related surface functionalization strategies |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Annulment or lapse of patent due to non-payment of fees |